Cisplatin- and Paclitaxel-Induced Apoptosis of Ovarian Carcinoma Cells and the Relationship between Bax and Bak Up-Regulation and the Functional Status of p53

This publication has 22 references indexed in Scilit:

• BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
  Journal of Cellular Biochemistry, 1996
• Small peptides activate the latent sequence-specific DNA binding function of p53
  Cell, 1995
• Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells
  Cytometry, 1995
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
  Cell, 1995
• Checkpoints of dueling dimers foil death wishes
  Cell, 1994
• Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
  Biochemical Pharmacology, 1994
• Increased accumulation of p53 protein in cisplatin‐resistant ovarian cell lines
  International Journal of Cancer, 1993
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Regulation of the specific DNA binding function of p53
  Cell, 1992
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
  The EMBO Journal, 1990